Clinical Trial Update: Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating OMEGAVEN 10% omega-3 fatty acid lipid emulsion for home parenteral nutrition-associated liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parenteral Nutrition Associated Liver Disease

Drugs mentioned

• OMEGAVEN 10% (omega-3 fatty acid lipid emulsion)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Liver Diseases | NA | Status: COMPLETED